DNA and RNA interference mechanisms by CRISPR-Cas surveillance complexes

FEMS Microbiology Reviews

Volumn 39, Issue 3, 2015, Pages 442-463

  Plagens, Andŕe ^a   Richter, Hagen ^b   Charpentier, Emmanuelle ^b,c,d   Randau, Lennart ^a  

^a MAX PLANCK INSTITUTE FOR TERRESTRIAL MICROBIOLOGY   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c UMEÅ UNIVERSITY   (Sweden)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cas9; Cascade; CRISPR; DNA interference; Guide crRNAs; Ribonucleoprotein complexes; TracrRNA; Viruses

Indexed keywords

BACTERIAL DNA; BACTERIAL PROTEIN; CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN; GUIDE RNA; RIBONUCLEOPROTEIN;

ADAPTIVE IMMUNITY; ARCHAEON; BACTERIAL GENE; CAS GENE; COMPLEX FORMATION; CRISPR CAS SYSTEM; CRYSTALLOGRAPHY; NONHUMAN; PROTEIN RNA BINDING; REVIEW; RNA INTERFERENCE; GENETIC VARIABILITY; GENETICS; METABOLISM; MOLECULAR EVOLUTION;

CRISPR-CAS SYSTEMS; DNA, BACTERIAL; EVOLUTION, MOLECULAR; GENETIC VARIATION; RIBONUCLEOPROTEINS; RNA INTERFERENCE;

EID: 84939232427     PISSN: 01686445     EISSN: 15746976     Source Type: Journal    
DOI: 10.1093/femsre/fuv019     Document Type: Review

References (158)

1. Agari Y, Yokoyama S, Kuramitsu S, et al. X-ray crystal structure of a CRISPR-associated protein, Cse2, from Thermus thermophilus HB8. Proteins 2008;73:1063-7.
2. Anders C, Niewoehner O, Duerst A, et al. Structural basis of PAMdependent target DNA recognition by the Cas9 endonuclease. Nature 2014;513:569-73.
3. Barrangou R, Fremaux C, Deveau H, et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 2007;315:1709-12.
4. Beloglazova N, Petit P, Flick R, et al. Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference. EMBO J 2011;30:4616-27.
5. Benda C, Ebert J, Scheltema RA, et al. Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4. Mol Cell 2014;56:43-54.
6. Blosser TR, LoeffL, Westra ER, et al. Two distinct DNA binding modes guide dual roles of a CRISPR-Cas protein complex. Mol Cell 2015;58:60-70.
7. Bondy-Denomy J, Pawluk A, Maxwell KL, et al. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 2013;493:429-32.
8. Brendel J, Stoll B, Lange SJ, et al. A complex of Cas proteins 5, 6, and 7 is required for the biogenesis and stability of clustered regularly interspaced short palindromic repeats (crispr)-derived rnas (crrnas) in Haloferax volcanii. J Biol Chem 2014;289:7164-77.
9. Briner AE, Donohoue PD, Gomaa AA, et al. Guide RNA functional modules direct Cas9 activity and orthogonality. Mol Cell 2014;56:333-9.
10. Brouns SJ, Jore MM, Lundgren M, et al. Small CRISPR RNAs guide antiviral defense in prokaryotes. Science 2008;321:960-4.
11. Carte J, Wang R, Li H, et al. Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes. Gene Dev 2008;22:3489-96.
12. Chen H, Choi J, Bailey S. Cut site selection by the two nuclease domains of the Cas9 RNA-guided endonuclease. J Biol Chem 2014;289:13284-94.
13. Chylinski K, Le Rhun A, Charpentier E. The tracrRNA and Cas9 families of type II CRISPR-Cas immunity systems. RNA Biol 2013;10:726-37.
14. Chylinski K, Makarova KS, Charpentier E, et al. Classification and evolution of type II CRISPR-Cas systems. Nucleic Acids Res 2014;42:6091-105.
15. Cocozaki AI, Ramia NF, Shao Y, et al. Structure of the Cmr2 subunit of the CRISPR-Cas RNA silencing complex. Structure 2012;20:545-53.
16. Cordin O, Banroques J, Tanner NK, et al. The DEAD-box protein family of RNA helicases. Gene 2006;367:17-37.
17. Datsenko KA, Pougach K, Tikhonov A, et al. Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system. Nat Commun 2012;3:945.
18. Daume M, Plagens A, Randau L. DNA binding properties of the small cascade subunit csa5. PLoS One 2014;9:e105716.
19. Deltcheva E, Chylinski K, Sharma CM, et al. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature 2011;471:602-7.
20. Deng L, Garrett RA, Shah SA, et al. A novel interference mechanism by a type IIIB CRISPR-Cmr module in Sulfolobus. Mol Microbiol 2013;87:1088-99.
21. Deveau H, Barrangou R, Garneau JE, et al. Phage response to CRISPR-encoded resistance in Streptococcus thermophilus. J Bacteriol 2008;190:1390-400.
22. Doudna JA, Charpentier E. Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 2014;346:1258096.
23. Ebihara A, Yao M, Masui R, et al. Crystal structure of hypothetical protein TTHB192 from Thermus thermophilus HB8 reveals a new protein family with an RNA recognition motif-like domain. Protein Sci 2006;15:1494-9.
24. Elmore JR, Yokooji Y, Sato T, et al. Programmable plasmid interference by the CRISPR-Cas system in Thermococcus kodakarensis. RNA Biol 2013;10:828-40.
25. Fairman-Williams ME, Guenther UP, Jankowsky E. SF1 and SF2 helicases: family matters. Curr Opin Struct Biol 2010;20: 313-24.
26. Fineran PC, Gerritzen MJ, Suarez-Diez M, et al. Degenerate target sites mediate rapid primed CRISPR adaptation. P Natl Acad Sci USA 2014;111:E1629-38.
27. Fischer S, Maier LK, Stoll B, et al. An archaeal immune system can detect multiple protospacer adjacent motifs (PAMs) to target invader DNA. J Biol Chem 2012;287:33351-63.
28. Fonfara I, LeRhun A, Chylinski K, et al. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems. Nucleic Acids Res 2014;42:2577-90.
29. Garneau JE, Dupuis ME, Villion M, et al. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature 2010;468:67-71.
30. Garside EL, Schellenberg MJ, Gesner EM, et al. Cas5d processes pre-crRNA and is a member of a larger family of CRISPR RNA endonucleases. RNA 2012;18:2020-8.
31. Gasiunas G, Barrangou R, Horvath P, et al. Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria. P Natl Acad Sci USA 2012;109:E2579-86.
32. Gesner EM, Schellenberg MJ, Garside EL, et al. Recognition and maturation of effector RNAs in a CRISPR interference pathway. Nat Struct Mol Biol 2011;18:688-92.
33. Godde JS, Bickerton A. The repetitive DNA elements called CRISPRs and their associated genes: evidence of horizontal transfer among prokaryotes. J Mol Evol 2006;62:718-29.
34. Goldberg GW, Jiang W, Bikard D, et al. Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting. Nature 2014;514:633-7.
35. Gong B, Shin M, Sun J, et al. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3. P Natl Acad Sci USA 2014;111:16359-64.
36. Grissa I, Vergnaud G, Pourcel C. Clustered regularly interspaced short palindromic repeats (CRISPRs) for the genotyping of bacterial pathogens. Methods Mol Biol 2009;551:105-16.
37. Haft DH, Selengut J, Mongodin EF, et al. A guild of 45 CRISPRassociated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes. PLoS Comput Biol 2005;1:e60.
38. Hale C, Kleppe K, Terns RM, et al. Prokaryotic silencing (psi)RNAs in Pyrococcus furiosus. RNA 2008;14:2572-9.
39. Hale CR, Cocozaki A, Li H, et al. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex. Gene Dev 2014;28:2432-43.
40. Hale CR, Majumdar S, Elmore J, et al. Essential features and rational design of CRISPR RNAs that function with the Cas RAMP module complex to cleave RNAs. Mol Cell 2012;45: 292-302.
41. Hale CR, Zhao P, Olson S, et al. RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 2009;139:945-56.
42. Hatoum-Aslan A, Maniv I, Marraffini LA. Mature clustered, regularly interspaced, short palindromic repeats RNA (cr- RNA) length is measured by a ruler mechanism anchored at the precursor processing site. P Natl Acad Sci USA 2011;108:21218-22.
43. Hatoum-Aslan A, Maniv I, Samai P, et al. Genetic characterization of antiplasmid immunity through a type III-A CRISPRCas system. J Bacteriol 2014;196:310-7.
44. Hatoum-Aslan A, Samai P, Maniv I, et al. A ruler protein in a complex for antiviral defense determines the length of small interfering CRISPR RNAs. J Biol Chem 2013;288:27888-97.
45. Haurwitz RE, Jinek M, Wiedenheft B, et al. Sequence- and structure-specific RNA processing by a CRISPR endonuclease. Science 2010;329:1355-8.
46. Haurwitz RE, Sternberg SH, Doudna JA. Csy4 relies on an unusual catalytic dyad to position and cleave CRISPR RNA. EMBO J 2012;31:2824-32.
47. Hein S, Scholz I, Voss B, et al. Adaptation and modification of three CRISPR loci in two closely related cyanobacteria. RNA Biol 2013;10:852-64.
48. Heler R, Samai P, Modell JW, et al. Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature 2015;519: 199-202.
49. Hochstrasser ML, Taylor DW, Bhat P, et al. CasA mediates Cas3-catalyzed target degradation during CRISPR RNA-guided interference. P Natl Acad Sci USA 2014;111:6618-23.
50. Horvath P, Barrangou R. CRISPR/Cas, the immune system of bacteria and archaea. Science 2010;327:167-70.
51. Hrle A, Maier LK, Sharma K, et al. Structural analyses of the CRISPR protein Csc2 reveal the RNA-binding interface of the type I-D Cas7 family. RNA Biol 2014;11:1072-82.
52. Hrle A, Su AA, Ebert J, et al. Structure and RNA-binding properties of the type III-A CRISPR-associated protein Csm3. RNA Biol 2013;10:1670-8.
53. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014;157:1262-78.
54. Huo Y, Nam KH, Ding F, et al. Structures of CRISPR Cas3 offer mechanistic insights into Cascade-activatedDNA unwinding and degradation. Nat Struct Mol Biol 2014;21:771-7.
55. Jackson RN, Golden SM, van Erp PB, et al. Crystal structure of the CRISPR RNA-guided surveillance complex from Escherichia coli. Science 2014a;345:1473-9.
56. Jackson RN, Lavin M, Carter J, et al. Fitting CRISPR-associated Cas3 into the Helicase Family Tree. Curr Opin Struct Biol 2014b;24:106-14.
57. Jansen R, van Embden JDA, Gaastra W, et al. Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol 2002;43:1565-75.
58. Jiang W, Maniv I, Arain F, et al. Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. PLoS Genet 2013;9:e1003844.
59. Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNAguided DNA endonuclease in adaptive bacterial immunity. Science 2012;337:816-21.
60. Jinek M, Jiang F, Taylor DW, et al. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science 2014;343:1247997.
61. Jore MM, Lundgren M, van Duijn E, et al. Structural basis for CRISPR RNA-guided DNA recognition by Cascade. Nat Struct Mol Biol 2011;18:529-36.
62. Jung TY, An Y, Park KH, et al. Crystal structure of the Csm1 subunit of the Csm complex and its single-stranded DNAspecific nuclease activity. Structure 2015, DOI: 10.1016/j.str. 2015.1001.1021.
63. Juranek S, Eban T, Altuvia Y, et al. A genome-wide view of the expression and processing patterns of Thermus thermophilus HB8 CRISPR RNAs. RNA 2012;18:783-94.
64. Karvelis T, Gasiunas G, Miksys A, et al. crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus. RNA Biol 2013;10:841-51.
65. Koo Y, Ka D, Kim EJ, et al. Conservation and variability in the structure and function of the Cas5d endoribonuclease in the CRISPR-mediated microbial immune system. J Mol Biol 2013;425:3799-810.
66. Koonin EV, Makarova KS. CRISPR-Cas: evolution of an RNAbased adaptive immunity system in prokaryotes. RNA Biol 2013;10:679-86.
67. Kunin V, Sorek R, Hugenholtz P. Evolutionary conservation of sequence and secondary structures in CRISPR repeats. Genome Biol 2007;8:R61.
68. Levin BR, Moineau S, Bushman M, et al. The population and evolutionary dynamics of phage and bacteria with CRISPRmediated immunity. PLoS Genet 2013;9:e1003312.
69. Li M, Liu H, Han J, et al. Characterization of CRISPR RNA biogenesis and Cas6 cleavage-mediated inhibition of a provirus in the haloarchaeon Haloferax mediterranei. J Bacteriol 2013;195:867-75.
70. Lintner NG, Kerou M, Brumfield SK, et al. Structural and functional characterization of an archaeal clustered regularly interspaced short palindromic repeat (CRISPR)-associated complex for antiviral defense (CASCADE). J Biol Chem 2011;286:21643-56.
71. Magadan AH, Dupuis ME, Villion M, et al. Cleavage of phage DNA by the Streptococcus thermophilus CRISPR3-Cas system. PLoS One 2012;7:e40913.
72. Makarova KS, Aravind L, Grishin NV, et al. A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis. Nucleic Acids Res 2002;30:482-96.
73. Makarova KS, Aravind L, Wolf YI, et al. Unification of Cas protein families and a simple scenario for the origin and evolution of CRISPR-Cas systems. Biol Direct 2011a;6:38.
74. Makarova KS, Grishin NV, Shabalina SA, et al. A putative RNAinterference- based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct 2006;1:7.
75. Makarova KS, Haft DH, Barrangou R, et al. Evolution and classification of the CRISPR-Cas systems. Nat Rev Microbiol 2011b;9:467-77.
76. Makarova KS, Wolf YI, Koonin EV. The basic building blocks and evolution of CRISPR-cas systems. Biochem Soc T 2013;41: 1392-400.
77. Maris C, Dominguez C, Allain FH. The RNA recognition motif, a plastic RNA-binding platform to regulate posttranscriptional gene expression. FEBS J 2005;272:2118-31.
78. Marraffini LA, Sontheimer EJ. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 2008;322:1843-5.
79. Marraffini LA, Sontheimer EJ. Self versus non-self discrimination during CRISPR RNA-directed immunity. Nature 2010;463: 568-71.
80. Martel B, Moineau S. CRISPR-Cas: an efficient tool for genome engineering of virulent bacteriophages. Nucleic Acids Res 2014;42:9504-13.
81. Millen AM, Horvath P, Boyaval P, et al. Mobile CRISPR/Casmediated bacteriophage resistance in Lactococcus lactis. PLoS One 2012;7:e51663.
82. Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, et al. Intervening sequences of regularly spaced prokaryotic repeats derive from foreign genetic elements. J Mol Evol 2005;60: 174-82.
83. Mojica FJ, Diez-Villasenor C, Garcia-Martinez J, et al. Short motif sequences determine the targets of the prokaryotic CRISPR defence system. Microbiology 2009;155:733-40.
84. Mulepati S, Bailey S. Structural and biochemical analysis of nuclease domain of clustered regularly interspaced short palindromic repeat (CRISPR)-associated protein 3 (Cas3). J Biol Chem 2011;286:31896-903.
85. Mulepati S, Bailey S. In vitro reconstitution of an Escherichia coli RNA-guided immune system reveals unidirectional, ATP-dependent degradation of DNA target. J Biol Chem 2013;288:22184-92.
86. Mulepati S, Heroux A, Bailey S. Crystal structure of a CRISPR RNA-guided surveillance complex bound to a ssDNA target. Science 2014;345:1479-84.
87. Mulepati S, Orr A, Bailey S. Crystal structure of the largest subunit of a bacterial RNA-guided immune complex and its role in DNA target binding. J Biol Chem 2012;287:22445-9.
88. Nam KH, Haitjema C, Liu X, et al. Cas5d protein processes pre-crRNA and assembles into a cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system. Structure 2012a;20:1574-84.
89. Nam KH, Huang Q, Ke A. Nucleic acid binding surface and dimer interface revealed by CRISPR-associated CasB protein structures. FEBS Lett 2012b;586:3956-61.
90. Niewoehner O, Jinek M, Doudna JA. Evolution of CRISPR RNA recognition and processing by Cas6 endonucleases. Nucleic Acids Res 2014;42:1341-53.
91. Nishimasu H, Ran FA, Hsu PD, et al. Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell 2014;156: 935-49.
92. Numata T, Inanaga H, Sato C, et al. Crystal structure of the Csm3-Csm4 subcomplex in the type III-A CRISPR-Cas interference complex. J Mol Biol 2015;427:259-73.
93. Nunez JK, Kranzusch PJ, Noeske J, et al. Cas1-Cas2 complex formation mediates spacer acquisition during CRISPR-Cas adaptive immunity. Nat Struct Mol Biol 2014;21:528-34.
94. Nunez JK, Lee AS, Engelman A, et al. Integrase-mediated spacer acquisition during CRISPR-Cas adaptive immunity. Nature 2015;519:193-8.
95. O'Connell MR, Oakes BL, Sternberg SH, et al. Programmable RNA recognition and cleavage by CRISPR/Cas9. Nature 2014;516:263-6.
96. Osawa T, Inanaga H, Numata T. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex. J Mol Biol 2013;425:3811-23.
97. Park JH, Sun J, Park SY, et al. Crystal structure of Cmr5 from Pyrococcus furiosus and its functional implications. FEBS Lett 2013;587:562-8.
98. Pawluk A, Bondy-Denomy J, Cheung VH, et al. A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa. MBio 2014;5:e00896.
99. Plagens A, Tjaden B, Hagemann A, et al. Characterization of the CRISPR/Cas subtype I-A system of the hyperthermophilic crenarchaeon Thermoproteus tenax. J Bacteriol 2012;194: 2491-500.
100. Plagens A, Tripp V, Daume M, et al. In vitro assembly and activity of an archaeal CRISPR-Cas type I-A Cascade interference complex. Nucleic Acids Res 2014;42:5125-38.
101. Pourcel C, Salvignol G, Vergnaud G. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 2005;151:653-63.
102. Przybilski R, Richter C, Gristwood T, et al. Csy4 is responsible for CRISPR RNA processing in Pectobacterium atrosepticum. RNA Biol 2011;8:517-28.
103. Punetha A, Sivathanu R, Anand B. Active site plasticity enables metal-dependent tuning of Cas5d nuclease activity in CRISPR-Cas type I-C system. Nucleic Acids Res 2014;42: 3846-56.
104. Ramia NF, Spilman M, Tang L, et al. Essential structural and functional roles of the Cmr4 subunit in RNA cleavage by the Cmr CRISPR-Cas complex. Cell Rep 2014a;9:1610-7.
105. Ramia NF, Tang L, Cocozaki AI, et al. Staphylococcus epidermidis Csm1 is a 3'-5' exonuclease. Nucleic Acids Res 2014b;42: 1129-38.
106. Reeks J, Graham S, Anderson L, et al. Structure of the archaeal Cascade subunit Csa5: relating the small subunits of CRISPR effector complexes. RNA Biol 2013a;10:762-9.
107. Reeks J, Naismith JH, White MF. CRISPR interference: a structural perspective. Biochem J 2013;453:155-66.
108. Reeks J, Sokolowski RD, Graham S, et al. Structure of a dimeric crenarchaeal Cas6 enzyme with an atypical active site for CRISPR RNA processing. Biochem J 2013b;452: 223-30.
109. Richter C, Fineran PC. The subtype I-F CRISPR-Cas system influences pathogenicity island retention in Pectobacterium atrosepticum via crRNA generation and Csy complex formation. Biochem Soc T 2013;41:1468-74.
110. Richter C, Gristwood T, Clulow JS, et al. In vivo protein interactions and complex formation in the Pectobacterium atrosepticum subtype I-F CRISPR/Cas System. PLoS One 2012a;7:e49549.
111. Richter H, Lange SJ, Backofen R, et al. Comparative analysis ofCas6b processing and CRISPR RNA stability. RNA Biol 2013;10:700-7.
112. Richter H, Zoephel J, Schermuly J, et al. Characterization of CRISPR RNA processing in Clostridium thermocellum and Methanococcus maripaludis. Nucleic Acids Res 2012b;40:9887-96.
113. Rollins MF, Schuman JT, Paulus K, et al. Mechanism of foreign DNA recognition by a CRISPR RNA-guided surveillance complex from Pseudomonas aeruginosa. Nucleic Acids Res 2015;43:2216-22.
114. Rouillon C, Zhou M, Zhang J, et al. Structure of the CRISPR interference complex CSM reveals key similarities with cascade. Mol Cell 2013;52:124-34.
115. Rutkauskas M, Sinkunas T, Songailiene I, et al. Directional Rloop formation by the CRISPR-Cas surveillance complex cascade provides efficient off-target site rejection. Cell Rep 2015;10:1534-43.
116. Sakamoto K, Agari Y, Agari K, et al. X-ray crystal structure of a CRISPR-associated RAMP module Cmr5 protein fromThermus thermophilus HB8. Proteins 2009;75:528-32.
117. Sampson TR, Saroj SD, Llewellyn AC, et al. A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature 2013;497:254-7.
118. Sampson TR, Weiss DS. Alternative roles for CRISPR/Cas systems in bacterial pathogenesis. PLoS Pathog 2013;9:e1003621.
119. Samson JE, Magadan AH, Sabri M, et al. Revenge of the phages: defeating bacterial defences. Nat Rev Microbiol 2013;11: 675-87.
120. Sapranauskas R, Gasiunas G, Fremaux C, et al. The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli. Nucleic Acids Res 2011;39:9275-82.
121. Sashital DG, Jinek M, Doudna JA. An RNA-induced conformational change required for CRISPR RNA cleavage by the endoribonuclease Cse3. Nat Struct Mol Biol 2011;18:680-7.
122. Sashital DG, Wiedenheft B, Doudna JA. Mechanism of foreign DNA selection in a bacterial adaptive immune system. Mol Cell 2012;46:606-15.
123. Savitskaya E, Semenova E, Dedkov V, et al. High-throughput analysis of type I-E CRISPR/Cas spacer acquisition in E. coli. RNA Biol 2013;10:716-25.
124. Scholz I, Lange SJ, Hein S, et al. CRISPR-Cas systems in the cyanobacterium Synechocystis sp. PCC6803 exhibit distinct processing pathways involving at least two Cas6 and a Cmr2 protein. PLoS One 2013;8:e56470.
125. Seed KD, Lazinski DW, Calderwood SB, et al. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 2013;494:489-91.
126. Semenova E, Jore MM, Datsenko KA, et al. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. P Natl Acad Sci USA 2011;108:10098-103.
127. Shah SA, Erdmann S, Mojica FJ, et al. Protospacer recognition motifs: mixed identities and functional diversity. RNA Biol 2013;10:891-9.
128. Shao Y, Cocozaki AI, Ramia NF, et al. Structure of the Cmr2-Cmr3 subcomplex of the Cmr RNA silencing complex. Structure 2013;21:376-84.
129. Shao Y, Li H. Recognition and cleavage of a nonstructured CRISPR RNA by its processing endoribonuclease Cas6. Structure 2013;21:385-93.
130. Sinkunas T, Gasiunas G, Fremaux C, et al. Cas3 is a singlestranded DNA nuclease and ATP-dependent helicase in the CRISPR/Cas immune system. EMBO J 2011;30:1335-42.
131. Sinkunas T, Gasiunas G, Waghmare SP, et al. In vitro reconstitution of Cascade-mediated CRISPR immunity in Streptococcus thermophilus. EMBO J 2013;32:385-94.
132. Sokolowski RD, Graham S, White MF. Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system. Nucleic Acids Res 2014;42:6532-41.
133. Spilman M, Cocozaki A, Hale C, et al. Structure of an RNA silencing complex of the CRISPR-Cas immune system. Mol Cell 2013;52:146-52.
134. Staals RH, Agari Y, Maki-Yonekura S, et al. Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus. Mol Cell 2013;52:135-45.
135. Staals RH, Zhu Y, Taylor DW, et al. RNA targeting by the type IIIA CRISPR-Cas Csm complex of Thermus thermophilus. Mol Cell 2014;56:518-30.
136. Sternberg SH, Haurwitz RE, Doudna JA. Mechanism of substrate selection by a highly specific CRISPR endoribonuclease. RNA 2012;18:661-72.
137. Sternberg SH, Redding S, Jinek M, et al. DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature 2014;507: 62-7.
138. Sun J, Jeon JH, Shin M, et al. Crystal structure and CRISPR RNAbinding site of the Cmr1 subunit of the Cmr interference complex. Acta Crystallogr D 2014;70:535-43.
139. Swarts DC, Mosterd C, van Passel MW, et al. CRISPR interference directs strand specific spacer acquisition. PLoS One 2012;7:e35888.
140. Szczelkun MD, Tikhomirova MS, Sinkunas T, et al. Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes. P Natl Acad Sci USA 2014;111:9798-803.
141. Takeuchi N, Wolf YI, Makarova KS, et al. Nature and intensity of selection pressure on CRISPR-associated genes. J Bacteriol 2012;194:1216-25.
142. Tamulaitis G, Kazlauskiene M, Manakova E, et al. Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus. Mol Cell 2014;56:506-17.
143. Tay M, Liu S, Yuan YA. Crystal structure of Thermobifida fusca Cse1 reveals target DNA binding site. Protein Sci 2015;24: 236-45.
144. van der Oost J, Westra ER, Jackson RN, et al. Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nat Rev Microbiol 2014;12:479-92.
145. Wang R, Zheng H, Preamplume G, et al. The impact of CRISPR repeat sequence on structures of a Cas6 protein-RNA complex. Protein Sci 2012;21:405-17.
146. Wasik BR, Turner PE. On the biological success of viruses. Annu Rev Microbiol 2013;67:519-41.
147. Wei Y, Terns RM, Terns MP. Cas9 function and host genome sampling in Type II-A CRISPR-Cas adaptation. Gene Dev 2015;29:356-61.
148. Westra ER, Buckling A, Fineran PC. CRISPR-Cas systems: beyond adaptive immunity. Nat Rev Microbiol 2014;12:317-26.
149. Westra ER, Nilges B, van Erp PB, et al. Cascade-mediated binding and bending of negatively supercoiled DNA. RNA Biol 2012a;9:1134-8.
150. Westra ER, Semenova E, Datsenko KA, et al. Type I-E CRISPRcas systems discriminate target from non-target DNA through base pairing-independent PAM recognition. PLoS Genet 2013;9:e1003742.
151. Westra ER, van Erp PB, Kunne T, et al. CRISPR immunity relies on the consecutive binding and degradation of negatively supercoiled invader DNA by Cascade and Cas3. Mol Cell 2012b;46:595-605.
152. Wiedenheft B, Lander GC, Zhou K, et al. Structures of the RNAguided surveillance complex from a bacterial immune system. Nature 2011a;477:486-9.
153. Wiedenheft B, van Duijn E, Bultema JB, et al. RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions. P Natl Acad Sci USA 2011b;108:10092-7.
154. Yosef I, Goren MG, Qimron U. Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res 2012;40:5569-76.
155. Zhang J, Rouillon C, Kerou M, et al. Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity. Mol Cell 2012;45:303-13.
156. Zhang Y, Heidrich N, Ampattu BJ, et al. Processing-independent CRISPR RNAs limit natural transformation in Neisseria meningitidis. Mol Cell 2013;50:488-503.
157. Zhao H, Sheng G, Wang J, et al. Crystal structure of the RNAguided immune surveillance Cascade complex in Escherichia coli. Nature 2014;515:147-50.
158. Zhu X, Ye K. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex. Nucleic Acids Res 2015;43:1257-67.